Molecular mechanisms of lncRNAs in regulating cancer cell radiosensitivity
Open Access
- 28 August 2019
- journal article
- review article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 39 (8)
Abstract
Radiotherapy is one of the main modalities of cancer treatment. However, tumor recurrence following radiotherapy occurs in many cancer patients. A key to solving this problem is the optimization of radiosensitivity. In recent years, long non-coding RNAs (lncRNAs), which affect the occurrence and development of tumors through a variety of mechanisms, have become a popular research topic. LncRNAs have been found to influence radiosensitivity by regulating various mechanisms, including DNA damage repair, cell cycle arrest, apoptosis, cancer stem cells regulation, epithelial–mesenchymal transition, and autophagy. LncRNAs are expected to become a potential therapeutic target for radiotherapy in the future. This article reviews recent advances in the role and mechanism of lncRNAs in tumor radiosensitivity.Keywords
This publication has 79 references indexed in Scilit:
- LincRNA-p21 Suppresses Target mRNA TranslationMolecular Cell, 2012
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the BreastCell, 2011
- PTEN Tumor Suppressor Network in PI3K-Akt Pathway ControlGenes & Cancer, 2010
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 ResponseCell, 2010
- The therapeutic promise of the cancer stem cell conceptJournal of Clinical Investigation, 2010
- Long non-coding RNAs: insights into functionsNature Reviews Genetics, 2009
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Differentiating Protein-Coding and Noncoding RNA: Challenges and AmbiguitiesPLOS Computational Biology, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006